Renal Cell Carcinoma: Prognostic Factors and Patient Selection{A figure is presented}

European Urology, Supplements

Volumn 6, Issue 7, 2007, Pages 477-483

  Belldegrun, Arie S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carbonic anhydrase IX; Molecular markers; Prognostic factors; Renal cell carcinoma; Staging system; Vascular endothelial growth factor

Indexed keywords

CARBONATE DEHYDRATASE IX; MOLECULAR MARKER; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; METASTASIS; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT RESPONSE;

EID: 33846821884     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2007.01.016     Document Type: Review

References (24)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Janzen N.K., Kim H.L., Figlin R.A., et al. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 30 (2003) 843-852
3. Ljungberg B, Hanbury DC, Kuczyk MA, et al. European Association of Urology guidelines on renal cell carcinoma 2006. Available at http://www.uroweb.nl/files/uploaded_files/guidelines/08%20Renal%20Cell%20Carcinoma.pdf. Accessed 21 July 2006.
4. Lam J.S., Shvarts O., Leppert J.T., et al. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 173 (2005) 1853-1862
5. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002.
6. Renal and adrenal tumours. Oxford: Oxford University Press; 2003. p. 309-17.
7. World Health Organization Classification of Tumours. Pathology & Genetics: Tumours of the urinary system and male genital organs (2004), IARC Press, Lyon
8. National Comprehensive Guidelines Network. Kidney cancer. Available at http://www.nccn.org/professionals/physician_gls/PDF/kidney.pdf. Accessed 16 November 2006.
9. Sobin L.H., and Wittekind C. TNM classification of malignant tumours. UICC International Union Against Cancer. 6th ed. (2003), Wiley-Liss, New York p. 193
10. Elson P.J., Witte R.S., and Trump D.L. Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48 (1988) 7310-7313
11. Motzer R.J., Bacik J., Murphy B.A., et al. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol 20 (2002) 289-296
12. Kattan M.W., Reuter V., Motzer R.J., et al. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166 (2001) 63-67
13. Frank I., Blute M.L., Cheville J.C., et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168 (2002) 2395-2400
14. Zisman A., Pantuck A.J., Dorey F., et al. Mathematical model to predict individual survival for patients with renal cell carcinoma. J Clin Oncol 20 (2002) 1368-1374
15. Zisman A., Pantuck A.J., Dorey F., et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19 (2001) 1649-1657
16. Zisman A., Pantuck A.J., Wieder J., et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20 (2002) 4559-4566
17. Patard J.J., Kim H.L., Lam J.S., et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 22 (2004) 3316-3322
18. Kononen J., Bubendorf L., Kallioniemi A., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4 (1998) 844-847
19. Kim H.L., Seligson D., Liu X., et al. Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res 10 (2004) 5464-5471
20. Bui M.H., Seligson D., Han K.R., et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9 (2003) 802-811
21. Atkins M., Regan M., McDermott D., et al. Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res 11 (2005) 3714-3721
22. Halbert R.J., Figlin R.A., Atkins M.B., et al. Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel. Cancer 107 (2006) 2375-2383
23. Leppert J.T., Lam J.S., Yu H., et al. Targeting the vascular endothelial growth factor pathway in renal cell carcinoma: a tissue array based analysis. J Clin Oncol 23 Suppl (2005) 386s (abstract no. 4536)
24. Lam J.S., Leppert J.T., Yu H., et al. Expression of the vascular endothelial growth factor family in tumor dissemination and disease free survival in clear cell renal cell carcinoma. J Clin Oncol 23 Suppl (2005) 387s (abstract no. 4538)